Observational studyPloS one2026
Prognostic value of red blood cell distribution width in traumatic brain injury: A mediation and deep learning analysis.
Observational study in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the associations between age, red blood cell distribution width (RDW), and short-term mortality in patients with traumatic brain injury (TBI), with a particular focus on the role of RDW in mediating the impact of age on mortality. We conducted a retrospective cohort analysis of 1,203 ICU-admitted TBI patients from the MIMIC-IV database (v3.1). Cox proportional hazards regression, restricted cubic splines (RCS), and mediation analysis were employed to evaluate the relationships between age, RDW, and mortality outcomes. Both advanced age (adjusted hazard ratio [HR] = 1.022 for 28-day mortality; HRadj = 1.031 for in-hospital mortality) and RDW (HRadj = 1.085 for 28-day mortality; HRadj = 1.094 for in-hospital mortality) were found to predict mortality (all P < 0.05) independently. RDW demonstrated a dose-response relationship with mortality: the highest quartile (Q4) exhibited a 2.061-fold increased risk of 28-day mortality (P = 0.010) and a 2.086-fold increased risk of in-hospital mortality (P = 0.022) compared to the lowest quartile (Q1). RCS analysis revealed significant nonlinear associations between age and 28-day mortality (P < 0.05) and between RDW and in-hospital mortality (P < 0.05). The mediation analysis demonstrated that RDW played a partial mediating role in age-related mortality, accounting for 4.40% of the total effect on 28-day mortality and 4.62% on in-hospital mortality (both P < 0.05). Deep learning survival models (e.g., Deepsurv: C-index: 0.759; IBS: 0.113; AUC (95% CI): 0.824 (0.735-0.900)) that incorporate age, RDW, and other clinical variables achieved robust predictive performance. Age and RDW are independent predictors of short-term mortality in TBI. RDW partially mediates the effect of age on TBI prognosis and shows potential as a practical biomarker for clinical risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.